ZABECOR PHARMACEUTICALS

zabecor-pharmaceuticals-logo

ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular technologies for the treatment of asthma, allergy, and other inflammatory and infectious diseases. Its products include Excellair, an anti-inflammatory treatment of asthma, allergy, ARDS, COPD, avian flu inflammation, uveitis, cystitis, rheumatoid arthritis, and other autoimmune and inflammatory diseases; Recruitin Phagocytosis for infection based on gene ther... apy; Disarmin Phagocytosis for autoimmune diseases based on gene therapy; and Hematrol Steroid for low blood platelets, anemia (hemolytic), rheumatoid arthritis, systemic lupus, ulcerative colitis, Crohn’s disease, psoriasis, and other steroid responsive autoimmune disorders. The company was founded in 1992 and is based in Bala Cynwyd, Pennsylvania.

#SimilarOrganizations #People #Website #More

ZABECOR PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Genetics Health Care

Founded:
1992-01-01

Address:
Bala Cynwyd, Pennsylvania, United States

Country:
United States

Website Url:
http://www.zabecor.com

Total Employee:
1+

Status:
Active

Contact:
610-660-7733

Total Funding:
50 K USD

Technology used in webpage:
Domain Not Resolving


Similar Organizations

dicerna-pharmaceuticals-logo

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.

regulus-therapeutics-logo

Regulus Therapeutics

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

Current Employees Featured

not_available_image

Alan D. Schreiber
Alan D. Schreiber CEO @ ZaBeCor Pharmaceuticals
CEO

Founder


not_available_image

Alan D. Schreiber

Official Site Inspections

http://www.zabecor.com

Unable to get host informations!!!

Loading ...

More informations about "ZaBeCor Pharmaceuticals"

linkstock.net © 2022. All rights reserved